May 30, 2017 09:58 AM EDTUpdated 10:19 AM
News Briefing

MannKind el­e­vates Cas­tan­ga to CEO; 23andMe re­cruits 5,000 women for study in 9 days

Emma Yasinski

→ Fi­nan­cial­ly-trou­bled MannKind el­e­vat­ed Michael Cas­tan­ga from chief com­mer­cial of­fi­cer to CEO. Matthew Pf­ef­fer, the out­go­ing chief ex­ec­u­tive, will con­tin­ue ad­vis­ing the com­pa­ny un­til …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

GSK's Ze­ju­la-Jem­per­li com­bo in ovar­i­an can­cer hits pri­ma­ry end­point, miss­es on over­all sur­vival

A service from the Financial Times